Full Text View
Tabular View
No Study Results Posted
Related Studies
Infliximab (Remicade(Registered Trademark)) to Treat Dermatomyositis and Polymyositis
This study has been completed.
Study NCT00033891   Information provided by National Institutes of Health Clinical Center (CC)

First Received on April 11, 2002.   Last Updated on May 1, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dermatomyositis
Polymyositis
More general conditions related to this trial
Connective Tissue Diseases
Muscular Diseases
Musculoskeletal Diseases
Myositis
Nervous System Diseases
Neuromuscular Diseases
Skin Diseases
Interventions listed in this trial
Infliximab
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antirheumatic Agents
Dermatologic Agents
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services